502
Participants
Start Date
September 30, 2003
Primary Completion Date
November 30, 2004
dabigatran with ASA
dose comparison in combination
dabigatran with ASA
dose comparison in combination
dabigatran with ASA
dose comparison in combination
dabigatran with ASA
dose comparison in combination
dabigatran with ASA
dose comparison in combination
dabigatran with ASA
dose comparison in combination
warfarin
comparator
dabigatran without ASA
dose comparison
dabigatran without ASA
dose comparison
dabigatran without ASA
dose comparison
1160.20.10010, Fayetteville
1160.20.10003 La Mesa Cardiac, La Mesa
1160.20.10006 The Ford Research Institute, PA, Pensacola
1160.20.10004, Port Charlotte
1160.20.10002, St. Petersburg
1160.20.10015, Baltimore
1160.20.10008, Westminister
1160.20.10012, Pittsfield
1160.20.10007, Troy
1160.20.10014, Hawthorne
1160.20.10013, New Hyde Park
1160.20.10009, North Durham
1160.20.10001, Philadelphia
1160.20.10005, Germantown
1160.20.45010, Aalborg
1160.20.45005 Aarhus Sygehus, Aarhus C
1160.20.45007 Medicinsk afdeling, Brædstrup
1160.20.45003 Forskningscentret plan 3, Elsinore
1160.20.45011 Medicinsk afd., Esbjerg
1160.20.45012 Afdeling B3, Frederikssund
1160.20.45004 Herlev Hospital, Herlev
1160.20.45009 Medicinsk amb. B8, Holbæk
1160.20.45002 Kardiologisk afdeling, Hvidovre
1160.20.45014 Hjertemedicinsk afd., Køge
1160.20.45001 Kardiologisk Laboratorium, Odense
1160.20.45013 Kardiologisk afd., Roskilde
1160.20.45006 Medicinsk afdeling, Svendborg
1160.20.46013 HIA, Mälarsjukhuset, Eskilstuna
1160.20.46007 Falu Lasarett, Falun
1160.20.46005 Ryhovs Länssjukhus, Jönköping
1160.20.46010 Länssjukhuset Kalmar, Kalmar
1160.20.46009 Universitetssjukhuset MAS, Malmo
1160.20.46008 Vrinnevisjukhuset, Norrköping
1160.20.46004 Universitetssjukhuset, Örebro
1160.20.46002 Södersjukhuset, Stockholm
1160.20.46011 Arytmienheten, Med klin, Stockholm
1160.20.46006 Norrlands Universitetssjukhus, Umeå
1160.20.46003 Centrallasarettet, Västerås
Lead Sponsor
Boehringer Ingelheim
INDUSTRY